Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Clinical trial NCT02688036 · COMPLETED

Trial details

NCT number: NCT02688036
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Small Cell Lung Neoplasms

Start date: 2016-02-01
Primary completion: 2022-10-01
Enrollment: 860

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.